Erythema migrans (Q28216120)

Medical Clinics of North America

Europe PubMed Central

title

Erythema migrans (English)

0 references

author name string

Jonathan A Edlow

series ordinal

1

0 references

language of work or name

English

0 references

publication date

March 2002

0 references

published in

0 references

volume

86

0 references

issue

2

0 references

page(s)

239-60

0 references

cites work

In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Comparison of azithromycin and doxycycline in the treatment of erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Borrelia lonestari DNA in adult Amblyomma americanum ticks, Alabama

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

A prospective study of tick bites in an endemic area for Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Reinfection in Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Solitary erythema migrans in Georgia and South Carolina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Racial differences in reported Lyme disease incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Vesicular erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Borrelia lonestari infection after a bite by an Amblyomma americanum tick

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Failure of treatment with cephalexin for Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Culture-confirmed infection and reinfection with Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Erythema Chronicum Migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Antibiotic therapy in Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3

Treatment failure in erythema migrans--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900085-3